SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer
(1) Background: Prostate cancer treatment efficacy is significantly influenced by androgen receptor (AR) signaling pathways. SLC22A3, a membrane transporter, has been linked to SNP rs9364554 risk loci for drug efficacy in prostate cancer. (2) Methods: We examined the location of SNP rs9364554 in the...
Saved in:
Main Authors: | Yuqian Yan, Lei Shi, Tao Ma, Liguo Wang, Haojie Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/1/64 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
by: Caihong Li, et al.
Published: (2025-02-01) -
The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01) -
Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1UK lineage
by: Johanna Richter, et al.
Published: (2025-02-01) -
Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups
by: Mohamed O. Andarawi, et al.
Published: (2025-02-01) -
The Usage of an SNP-SNP Relationship Matrix for Best Linear Unbiased Prediction (BLUP) Analysis Using a Community-Based Cohort Study
by: Young-Sup Lee, et al.
Published: (2014-12-01)